It was published on Jan. 6 in JAMA Internal Medicine. DoxyPEP is a new strategy for preventing STIs that involves taking a dose of doxycycline, a common and well-tolerated antibiotic medication, ...

Both studies in JAMA Internal Medicine supported the rising profile of doxyPEP as a way to counter the epidemic of syphilis, gonorrhea, and chlamydia infections, even if the data ...

While the use of PrEP has helped drop the rates of HIV infections, instances of syphilis and chlamydia among queer men have been skyrocketing, but a new study shows that doxyPEP may be the answer to ...

The early rollout of doxyPEP — a dose of the antibiotic doxycycline after sex — has contributed to a decline in sexually transmitted infections in Northern California, according to a pair of studies ...

Quarterly syphilis rates decreased from 1.7% prior to doxyPEP availability to 0.3% afterward, while quarterly chlamydia rates declined from 9.6% to 2%. Quarterly gonorrhea infections dropped from 10.2 ...

Worried about the risky sex you had last night? Using a common antibiotic following sex can dramatically reduce a person's risk of some sexually transmitted infections, a new study says.

After years of rising rates of syphilis and chlamydia among queer men, it appears a new tool is helping to curb infections. A study says that taking DoxyPEP reduced the incidence of chlamydia and ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

"These findings suggest that doxyPEP may offer substantial benefits for reducing population-level STI transmission with broader implementation." HealthDay News — Doxycycline postexposure ...

A new study has found that rates of chlamydia and syphilis plummet among people prescribed doxycycline for sexually transmitted infection prevention in routine clinical care. The study was led by ...

Taking doxycycline within 72 hours after sex reduced risk of chlamydia by 79%, syphilis by 80%, and gonorrhea by 12%, results published in JAMA Internal Medicine show. Adobe Stock Worried about ...